Trial Condition(s):

Diabetes Mellitus, Type 1

Efficacy and tolerability of acarbose (BAY g 5421) compared with placebo in diabetic children on conventional insulin treatment

Bayer Identifier:

Trial_0665

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Terminated/Withdrawn

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
25
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
No
Products
Acarbose (Precose/Glucobay, BAYG5421)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

For details, please refer to trial results

Additional Information